Skip to content
1887

Abstract

Novel treatment options are needed for the gastric pathogen due to its increasing antibiotic resistance. The vitamin K analogue menadione has been extensively studied due to interest in its anti-bacterial and anti-cancer properties. Here, we investigated the effects of menadione on growth, viability, antibiotic resistance, motility and gene expression using clinical isolates. The MIC of menadione was 313 µM for 11/13 isolates and 156 µM for 2/13 isolates. The minimum bactericidal concentrations were 1.25–2.5 mM, indicating that concentrations in the micromolar range were bacteriostatic rather than bactericidal. We were not able to experimentally evolve resistance to menadione . Sub-MIC menadione (16 µM for 24 h) did not significantly inhibit bacterial growth but significantly (<0.05) changed the expression of 1291/1615 (79.9%) genes encoded by strain 322A. The expression of the virulence factor genes and was downregulated in the presence of sub-MIC menadione, while genes involved in stress responses were upregulated. Sub-MIC menadione significantly (<0.0001) inhibited the motility of , consistent with the predicted effects of the observed significant (<0.05) downregulation of , upregulation of and changes in the expression of flagellar assembly pathway genes seen in the transcriptomic analysis. Through in-depth interrogation of transcriptomic data, we concluded that sub-MIC menadione elicits a general stress response in with survival in the stationary phase likely mediated by the upregulation of and . Sub-MIC menadione caused some modest increases in susceptibility to antibiotics, but the effect was variable with strain and antibiotic type and did not reach statistical significance. Menadione (78 µM) was minimally cytotoxic to human gastric adenocarcinoma (AGS) cells after 4 h but caused a significant loss of cell viability after 24 h. Given its inhibitory effects on bacterial growth, motility and expression of virulence- and colonization-associated genes, menadione at low micromolar concentrations may have potential utility as a virulence-attenuating agent against .

Funding
This study was supported by the:
  • Nottingham Trent University
    • Principal Award Recipient: StephenThompson
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001539
2025-03-12
2026-02-19

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/micro/171/3/mic001539.html?itemId=/content/journal/micro/10.1099/mic.0.001539&mimeType=html&fmt=ahah

References

  1. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 2003; 125:1636–1644 [View Article] [PubMed]
    [Google Scholar]
  2. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133:926–936 [View Article] [PubMed]
    [Google Scholar]
  3. Matos JI, de Sousa HAC, Marcos-Pinto R, Dinis-Ribeiro M. Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis. Eur J Gastroenterol Hepatol 2013; 25:1431–1441 [View Article] [PubMed]
    [Google Scholar]
  4. Garvey E, Rhead J, Suffian S, Whiley D, Mahmood F et al. High incidence of antibiotic resistance amongst isolates of Helicobacter pylori collected in Nottingham, UK, between 2001 and 2018. J Med Microbiol 2023; 72: [View Article]
    [Google Scholar]
  5. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) Scientific opinion on the safety and efficacy of vitamin K3 (menadione sodium bisulphite and menadione nicotinamide bisulphite) as a feed additive for all animal species. EFS2 2014; 12: [View Article]
    [Google Scholar]
  6. Lamson DW, Plaza SM. The anticancer effects of vitamin K. Altern Med Rev J Clin Ther 2003; 8:303–318
    [Google Scholar]
  7. Sun JS, Tsuang YH, Huang WC, Chen LT, Hang YS et al. Menadione-induced cytotoxicity to rat osteoblasts. Cell Mol Life Sci 1997; 53:967–976 [View Article] [PubMed]
    [Google Scholar]
  8. Suresh S, Raghu D, Karunagaran D. Menadione (Vitamin K3) induces apoptosis of human oral cancer cells and reduces their metastatic potential by modulating the expression of epithelial to mesenchymal transition markers and inhibiting migration. Asian Pac J Cancer Prev 2013; 14:5461–5465 [View Article] [PubMed]
    [Google Scholar]
  9. Marchionatti AM, Picotto G, Narvaez CJ, Welsh J, Tolosa de Talamoni NG. Antiproliferative action of menadione and 1,25(OH)2D3 on breast cancer cells. J Steroid Biochem Mol Biol 2009; 113:227–232 [View Article] [PubMed]
    [Google Scholar]
  10. Oztopcu-Vatan P, Sayitoglu M, Gunindi M, Inan E. Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells. Cytotechnology 2015; 67:1003–1009 [View Article] [PubMed]
    [Google Scholar]
  11. Schlievert PM, Merriman JA, Salgado-Pabón W, Mueller EA, Spaulding AR et al. Menaquinone analogs inhibit growth of bacterial pathogens. Antimicrob Agents Chemother 2013; 57:5432–5437 [View Article] [PubMed]
    [Google Scholar]
  12. Andrade JC, Morais Braga MFB, Guedes GMM, Tintino SR, Freitas MA et al. Menadione (vitamin K) enhances the antibiotic activity of drugs by cell membrane permeabilization mechanism. Saudi J Biol Sci 2017; 24:59–64 [View Article]
    [Google Scholar]
  13. Park B-S, Lee H-K, Lee S-E, Piao X-L, Takeoka GR et al. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J Ethnopharmacol 2006; 105:255–262 [View Article] [PubMed]
    [Google Scholar]
  14. Lee MH, Yang JY, Cho Y, Woo HJ, Kwon HJ et al. Inhibitory effects of menadione on Helicobacter pylori growth and Helicobacter pylori-induced inflammation via NF-κB inhibition. Int J Mol Sci 2019; 20:1169 [View Article] [PubMed]
    [Google Scholar]
  15. Marcus EA, Sachs G, Scott DR. Acid-regulated gene expression of Helicobacter pylori: insight into acid protection and gastric colonization. Helicobacter 2018; 23:e12490 [View Article] [PubMed]
    [Google Scholar]
  16. Loh JT, Beckett AC, Scholz MB, Cover TL. High-salt conditions alter transcription of Helicobacter pylori genes encoding outer membrane proteins. Infect Immun 2018; 86:e00626-17 [View Article] [PubMed]
    [Google Scholar]
  17. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. Epidemiol Infect 1938; 38:732–749 [View Article]
    [Google Scholar]
  18. Afgan E, Baker D, Batut B, van den Beek M, Bouvier D et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res 2018; 46:W537–W544 [View Article] [PubMed]
    [Google Scholar]
  19. Wilkinson DJ, Dickins B, Robinson K, Winter JA. Genomic diversity of Helicobacter pylori populations from different regions of the human stomach. Gut Microbes 2022; 14:2152306 [View Article] [PubMed]
    [Google Scholar]
  20. Wingett SW, Andrews S. FastQ Screen: a tool for multi-genome mapping and quality control. F1000Res 2018; 7:1338 [View Article] [PubMed]
    [Google Scholar]
  21. Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 2019; 37:907–915 [View Article] [PubMed]
    [Google Scholar]
  22. Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014; 30:923–930 [View Article] [PubMed]
    [Google Scholar]
  23. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15:550 [View Article] [PubMed]
    [Google Scholar]
  24. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P et al. A novel signaling pathway impact analysis. Bioinforma Oxf Engl 2009; 25:75–82 [View Article]
    [Google Scholar]
  25. Zhang JD, Wiemann S. KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinforma Oxf Engl 2009; 25:1470–1471 [View Article]
    [Google Scholar]
  26. Csardi G, Nepusz T. The igraph software package for complex network research. InterJ 2006; Complex Systems:1695
    [Google Scholar]
  27. Gustavsen JA, Pai S, Isserlin R, Demchak B, Pico AR. RCy3: network biology using Cytoscape from within R. F1000Res 2019; 8:1774 [View Article] [PubMed]
    [Google Scholar]
  28. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13:2498–2504 [View Article] [PubMed]
    [Google Scholar]
  29. Hoyles L, Pontifex MG, Rodriguez-Ramiro I, Anis-Alavi MA, Jelane KS et al. Regulation of blood-brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide. Microbiome 2021; 9:235 [View Article] [PubMed]
    [Google Scholar]
  30. Francke C, Groot Kormelink T, Hagemeijer Y, Overmars L, Sluijter V et al. Comparative analyses imply that the enigmatic sigma factor 54 is a central controller of the bacterial exterior. BMC Genomics 2011; 12:385 [View Article] [PubMed]
    [Google Scholar]
  31. Inatsu S, Ohsaki A, Nagata K. Idebenone acts against growth of Helicobacter pylori by inhibiting its respiration. Antimicrob Agents Chemother 2006; 50:2237–2239 [View Article] [PubMed]
    [Google Scholar]
  32. Gupta A, Imlay JA. How a natural antibiotic uses oxidative stress to kill oxidant-resistant bacteria. Proc Natl Acad Sci USA 2023; 120:e2312110120 [View Article] [PubMed]
    [Google Scholar]
  33. Jahn LJ, Munck C, Ellabaan MMH, Sommer MOA. Adaptive laboratory evolution of antibiotic resistance using different selection regimes lead to similar phenotypes and genotypes. Front Microbiol 2017; 8:816 [View Article] [PubMed]
    [Google Scholar]
  34. Maeda T, Iwasawa J, Kotani H, Sakata N, Kawada M et al. High-throughput laboratory evolution reveals evolutionary constraints in Escherichia coli. Nat Commun 2020; 11:5970 [View Article] [PubMed]
    [Google Scholar]
  35. Comtois SL. Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori. Microbiology 2003; 149:121–129 [View Article] [PubMed]
    [Google Scholar]
  36. Li C, Wu PY, Hsieh M. Growth-phase-dependent transcriptional regulation of the pcm and surE genes required for stationary-phase survival of Escherichia coli. Microbiol Read Engl 1997; 143:3513–3520 [View Article]
    [Google Scholar]
  37. Sun Y, Liu S, Li W, Shan Y, Li X et al. roteomic analysis of the function of sigma factor σ54 in Helicobacter pylori survival with nutrition deficiency stress in vitro. PLoS One 2013; 8:e72920 [View Article]
    [Google Scholar]
  38. Kazmierczak MJ, Wiedmann M, Boor KJ. Alternative sigma factors and their roles in bacterial virulence. Microbiol Mol Biol Rev 2005; 69:527–543 [View Article]
    [Google Scholar]
  39. Tarique KF, Abdul Rehman SA, Devi S, Tomar P, Gourinath S. Structural and functional insights into the stationary-phase survival protein SurE, an important virulence factor of Brucella abortus. Acta Crystallogr F Struct Biol Commun 2016; 72:386–396 [View Article] [PubMed]
    [Google Scholar]
  40. Natrajan G, Noirot-Gros MF, Zawilak-Pawlik A, Kapp U, Terradot L. The structure of a DnaA/HobA complex from Helicobacter pylori provides insight into regulation of DNA replication in bacteria. Proc Natl Acad Sci USA 2009; 106:21115–21120 [View Article] [PubMed]
    [Google Scholar]
  41. Slager J, Kjos M, Attaiech L, Veening JW. Antibiotic-induced replication stress triggers bacterial competence by increasing gene dosage near the origin. Cell 2014; 157:395–406 [View Article] [PubMed]
    [Google Scholar]
  42. Karnholz A, Hoefler C, Odenbreit S, Fischer W, Hofreuter D et al. Functional and topological characterization of novel components of the comB DNA transformation competence system in Helicobacter pylori. J Bacteriol 2006; 188:882–893 [View Article] [PubMed]
    [Google Scholar]
  43. Hofreuter D, Odenbreit S, Haas R. Natural transformation competence in Helicobacter pylori is mediated by the basic components of a type IV secretion system. Mol Microbiol 2001; 41:379–391 [View Article] [PubMed]
    [Google Scholar]
  44. Engelmoer DJP, Rozen DE. Competence increases survival during stress in Streptococcus pneumoniae. Evolution 2011; 65:3475–3485 [View Article] [PubMed]
    [Google Scholar]
  45. Kaźmierczak-Barańska J, Karwowski BT. Vitamin K contribution to DNA damage—advantage or disadvantage? A human health response. Nutrients 2022; 14:4219 [View Article] [PubMed]
    [Google Scholar]
  46. Seitz P, Blokesch M. Cues and regulatory pathways involved in natural competence and transformation in pathogenic and environmental Gram-negative bacteria. FEMS Microbiol Rev 2013; 37:336–363 [View Article] [PubMed]
    [Google Scholar]
  47. Dorer MS, Fero J, Salama NR. DNA damage triggers genetic exchange in Helicobacter pylori. PLoS Pathog 2010; 6:e1001026 [View Article] [PubMed]
    [Google Scholar]
  48. Pereira L, Hoover TR. Stable accumulation of sigma54 in Helicobacter pylori requires the novel protein HP0958. J Bacteriol 2005; 187:4463–4469 [View Article] [PubMed]
    [Google Scholar]
  49. Doherty NC, Shen F, Halliday NM, Barrett DA, Hardie KR et al. In Helicobacter pylori, LuxS is a key enzyme in cysteine provision through a reverse transsulfuration pathway. J Bacteriol 2010; 192:1184–1192 [View Article] [PubMed]
    [Google Scholar]
  50. Lee WK, Ogura K, Loh JT, Cover TL, Berg DE. Quantitative effect of luxS gene inactivation on the fitness of Helicobacter pylori. Appl Environ Microbiol 2006; 72:6615–6622 [View Article] [PubMed]
    [Google Scholar]
  51. Osaki T, Hanawa T, Manzoku T, Fukuda M, Kawakami H et al. Mutation of luxs affects motility and infectivity of Helicobacter pylori in gastric mucosa of a mongolian gerbil model. J Med Microbiol 2006; 55:1477–1485
    [Google Scholar]
  52. Loughlin MF, Barnard FM, Jenkins D, Sharples GJ, Jenks PJ. Helicobacter pylori mutants defective in RuvC holliday junction resolvase display reduced macrophage survival and spontaneous clearance from the murine gastric mucosa. Infect Immun 2003; 71:2022–2031 [View Article]
    [Google Scholar]
  53. Ha NC, Oh ST, Sung JY, Cha KA, Lee MH et al. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol 2001; 8:505–509
    [Google Scholar]
  54. Hu LT, Foxall PA, Russell R, Mobley HL. Purification of recombinant Helicobacter pylori urease apoenzyme encoded by ureA and ureB. Infect Immun 1992; 60:2657–2666 [View Article]
    [Google Scholar]
  55. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991; 173:1920–1931
    [Google Scholar]
  56. Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science 2000; 287:482–485 [View Article] [PubMed]
    [Google Scholar]
  57. Skouloubris S, Thiberge JM, Labigne A, De Reuse H. The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun 1998; 66:4517–4521 [View Article] [PubMed]
    [Google Scholar]
  58. Debowski AW, Walton SM, Chua E-G, Tay AC-Y, Liao T et al. Helicobacter pylori gene silencing in vivo demonstrates urease is essential for chronic infection. PLoS Pathog 2017; 13:e1006464 [View Article]
    [Google Scholar]
  59. Kavermann H, Burns BP, Angermuller K, Odenbreit S, Fischer W et al. Identification and characterization of Helicobacter pylori genes essential for gastric colonization. J Exp Med 2003; 197:813–822 [View Article] [PubMed]
    [Google Scholar]
  60. Lytton SD, Fischer W, Nagel W, Haas R, Beck FX. Production of ammonium by Helicobacter pylori mediates occludin processing and disruption of tight junctions in Caco-2 cells. Microbiology 2005; 151:3267–3276 [View Article] [PubMed]
    [Google Scholar]
  61. Wroblewski LE, Shen L, Ogden S, Romero-Gallo J, Lapierre LA et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. Gastroenterology 2009; 136:236–246 [View Article] [PubMed]
    [Google Scholar]
  62. Beswick EJ, Pinchuk IV, Minch K, Suarez G, Sierra JC et al. The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-κB activation and interleukin-8 production. Infect Immun 2006; 74:1148–1155 [View Article]
    [Google Scholar]
  63. Harris PR, Mobley HL, Perez-Perez GI, Blaser MJ, Smith PD. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996; 111:419–425 [View Article] [PubMed]
    [Google Scholar]
  64. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93:14648–14653 [View Article] [PubMed]
    [Google Scholar]
  65. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105:1003–1008 [View Article] [PubMed]
    [Google Scholar]
  66. Neal JT, Peterson TS, Kent ML, Guillemin K. H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model. Dis Model Mech 2013; 6:802–810 [View Article] [PubMed]
    [Google Scholar]
  67. White JR, Winter JA, Robinson K. Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes. J Inflamm Res 2015; 8:137–147 [View Article] [PubMed]
    [Google Scholar]
  68. Foegeding NJ, Caston RR, McClain MS, Ohi MD, Cover TL. An overview of Helicobacter pylori vaca toxin biology. Toxins 2016; 8:173 [View Article] [PubMed]
    [Google Scholar]
  69. Osada S, Tomita H, Tanaka Y, Tokuyama Y, Tanaka H et al. The utility of vitamin K3 (menadione) against pancreatic cancer. Anticancer Res 2008; 28:45–50 [PubMed]
    [Google Scholar]
  70. Lee MH, Cho Y, Kim DH, Woo HJ, Yang JY et al. Menadione induces G2/M arrest in gastric cancer cells by down-regulation of CDC25C and proteasome mediated degradation of CDK1 and cyclin B1. Am J Transl Res 2016; 8:5246–5255
    [Google Scholar]
  71. Lee MH, Yang JY, Cho Y, Park M, Woo HJ et al. Menadione induces apoptosis in a gastric cancer cell line mediated by down-regulation of X-linked inhibitor of apoptosis. Int J Clin Exp Med 2016; 9:2437–2443
    [Google Scholar]
  72. Shahzad S, Ashraf MA, Sajid M, Shahzad A, Rafique A et al. Evaluation of synergistic antimicrobial effect of vitamins (A, B1, B2, B6, B12, C, D, E and K) with antibiotics against resistant bacterial strains. J Glob Antimicrob Resist 2018; 13:231–236 [View Article] [PubMed]
    [Google Scholar]
  73. Li LH, Lu HF, Liu YF, Lin YT, Yang TC. FadACB and smeU1VWU2X contribute to oxidative stress-mediated fluoroquinolone resistance in Stenotrophomonas maltophilia.. Antimicrob Agents Chemother 2022; 66:e0204321 [View Article] [PubMed]
    [Google Scholar]
  74. Blanco P, Corona F, Sánchez MB, Martínez JL. Vitamin K3 induces the expression of the Stenotrophomonas maltophilia SmeVWX multidrug efflux pump. Antimicrob Agents Chemother 2017; 61:e02453-16 [View Article] [PubMed]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.001539
Loading
/content/journal/micro/10.1099/mic.0.001539
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error